IGC Pharma, Inc. Cash And Cash Equivalents At Carrying Value

• IGC Pharma, Inc. showed a decrease of -66.2% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
• This data is from IGC Pharma, Inc.'s annual report (Form 10-K), filed with the SEC on June 27, 2025.
• XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 16 years of available data (2010 to 2025), IGC Pharma, Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 52.0%.
• Historical annual values: Fiscal year 2025: $405.0 thousand | Fiscal year 2024: $1.20 million | Fiscal year 2023: $3.20 million | Fiscal year 2022: $10.46 million | Fiscal year 2021: $14.55 million | Fiscal year 2020: $7.26 million | Fiscal year 2019: $25.61 million | Fiscal year 2018: $1.66 million | Fiscal year 2017: $538.0 thousand | Fiscal year 2016: $1.49 million | Fiscal year 2015: $824.5 thousand | Fiscal year 2014: $1.03 million | Fiscal year 2013: $1.06 million | Fiscal year 2012: $562.9 thousand | Fiscal year 2011: $1.58 million | Fiscal year 2010: $842.9 thousand.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026